Pulse Biosciences
PLSE
43 hedge funds and large institutions have $28.3M invested in Pulse Biosciences in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 14 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
0.92% more ownership
Funds ownership: 9.69% → 10.6% (+0.92%)
12% less funds holding
Funds holding: 49 → 43 (-6)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
40% less capital invested
Capital invested by funds: $47.4M → $28.3M (-$19.1M)
60% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $2.82M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$1.7M |
| 2 |
BlackRock
New York
|
+$945K |
| 3 |
Bank of New York Mellon
New York
|
+$672K |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$454K |
| 5 |
LCS
Levin Capital Strategies
New York
|
+$341K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$409K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
-$349K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$325K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$310K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$297K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$233K | -6,760 | Closed |
|
52
Creative Planning
Overland Park,
Kansas
| – | -$10K | -300 | Closed |
|
|
AIM
53
Acrospire Investment Management
Chicago,
Illinois
| – | -$8K | -222 | Closed |
|
|
LTFS
54
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$7K | -217 | Closed |
|
55
JP Morgan Chase
New York
| – | -$6K | -160 | Closed |
|
56
Citigroup
New York
| – | -$2K | -61 | Closed |
|
|
SSB
57
Sandy Spring Bank
Olney,
Maryland
| – | -$1K | -15 | Closed |
|
PLSE Hedge Fund Activity: Q3 2017 in Review
43 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2017, worth a combined $28.3M — down 40% from $47.4M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of PLSE and 9 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 16 added.
The largest buyer was Harvest Capital Strategies, opening a new position worth an estimated $1.7M. The largest seller was Cadence Capital Management, exiting entirely with an estimated $409K sold.
- 43 institutional investors held Pulse Biosciences (PLSE) as of Q3 2017, down from 49 in Q2 2017.
- Funds reported $28.3M of Pulse Biosciences stock for Q3 2017, down 40% quarter-over-quarter.
- 9 funds opened new Pulse Biosciences positions in Q3 2017 and 14 closed out, a net change of -5 holders.
- The largest Pulse Biosciences buyer in Q3 2017 was Harvest Capital Strategies, an estimated $1.7M added.
- The largest Pulse Biosciences seller in Q3 2017 was Cadence Capital Management, an estimated $409K sold.
Based on aggregated 13F filings for Q3 2017.